WallStreetZenWallStreetZen
Analyst Ranking
Top 6%
#232 out of 4527 analysts
Average Return
+22.88%
Win Rate
55%47 out of 86
Risk vs Reward
Poor
Good

Joshua Schimmer's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Longboard Pharmaceuticals IncLBPH
+305.80%$5.17$20.98
2023-10-23 -
2024-03-27
Strong Buy
Longboard Pharmaceuticals IncLBPH
+280.07%$5.52$20.98
2023-12-19 -
2024-03-27
Strong Buy
Longboard Pharmaceuticals IncLBPH
+271.99%$5.64$20.98
2023-12-18 -
2024-03-27
Strong Buy
4d Molecular Therapeutics IncFDMT
+240.97%$10.52$35.87
2023-10-23 -
2024-03-27
Strong Buy
Voyager Therapeutics IncVYGR
+183.31%$8.57$24.28
2017-08-16 -
2018-03-12
Buy

Joshua Schimmer's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Cabaletta Bio IncCABA
3Strong Buy$50.00+191.55%Reiterates
6 days ago
Janux Therapeutics IncJANX
1Strong Buy$100.00+163.71%Initiates Coverage On
9 days ago
Bridgebio Pharma IncBBIO
5Strong Buy$70.00+126.83%Maintains
10 days ago
Longboard Pharmaceuticals IncLBPH
7Strong Buy$60.00+185.99%Reiterates
16 days ago
Crinetics Pharmaceuticals IncCRNX
4Strong Buy$65.00+46.30%Maintains
25 days ago
Mirum Pharmaceuticals IncMIRM
5Strong Buy$40.00+59.24%Maintains
25 days ago
Rocket Pharmaceuticals IncRCKT
3Strong Buy$65.00+138.53%Maintains
a month ago
Cg Oncology IncCGON
1Strong Buy$75.00+82.93%Initiates Coverage On
a month ago
Rallybio CorpRLYB
2Buy$15.00+843.40%Maintains
3 months ago
Krystal Biotech IncKRYS
3Strong Buy$180.00+1.58%Maintains
4 months ago
Ventyx Biosciences IncVTYX
2Hold$5.00-13.87%Downgrades
5 months ago
4d Molecular Therapeutics IncFDMT
1Strong Buy$32.00-10.79%Initiates Coverage On
5 months ago
Insmed IncINSM
2Buy$42.00+53.73%Maintains
7 months ago
Otis Worldwide CorpOTIS
4Hold$92.00-7.87%Maintains
8 months ago
Chinook Therapeutics IncKDNY
1Hold$40.00-0.97%Downgrades
9 months ago
Erasca IncERAS
2Buy$11.00+433.98%Maintains
10 months ago
Avidity Biosciences IncRNA
3Buy$20.00-18.93%Upgrades
10 months ago
Bellus Health IncBLU
3Hold$14.75+0.07%Downgrades
a year ago
Atreca IncBCEL
1Hold$1.50+900.00%Downgrades
a year ago
Seagen IncSGEN
1Hold$229.00N/ADowngrades
a year ago
Bionomics LimitedBNOX
2Buy$6.00N/AUpgrades
a year ago
Neurocrine Biosciences IncNBIX
2Buy$130.00N/AUpgrades
a year ago
Denali Therapeutics IncDNLI
3Buy$50.00N/AMaintains
a year ago
Tg Therapeutics IncTGTX
3Buy$25.00N/AMaintains
a year ago
Myovant Sciences LtdMYOV
3Hold$27.00N/ADowngrades
a year ago
Regeneron Pharmaceuticals IncREGN
3Hold$760.00N/ADowngrades
a year ago
Spero Therapeutics IncSPRO
3Buy$8.00N/AUpgrades
2 years ago
Zymeworks IncZYME
1Buy$15.00N/AInitiates Coverage On
2 years ago
Icosavax IncICVX
1Buy$50.00N/AInitiates Coverage On
3 years ago
Tourmaline Bio IncTRML
1Buy$35.00N/AInitiates Coverage On
3 years ago
Viracta Therapeutics IncVIRX
1Buy$45.00N/AInitiates Coverage On
3 years ago
Biomarin Pharmaceutical IncBMRN
2Buy$100.00N/AUpgrades
3 years ago
Cullinan Oncology IncCGEM
1Buy$55.00N/AInitiates Coverage On
3 years ago
Beyondspring IncBYSI
1Buy$30.00N/AInitiates Coverage On
3 years ago
Freeline Therapeutics Holdings PLCFRLN
1Buy$480.00N/AInitiates Coverage On
4 years ago
Cymabay Therapeutics IncCBAY
1Buy$15.00N/AUpgrades
4 years ago
Bluebird Bio IncBLUE
4Buy$100.00N/AUpgrades
4 years ago
Regenxbio IncRGNX
3BuyN/AN/AUpgrades
5 years ago
Madrigal Pharmaceuticals IncMDGL
2Buy$250.00N/AUpgrades
5 years ago
Shire PLCSHPG
2HoldN/AN/ADowngrades
6 years ago
Incyte CorpINCY
3Strong Buy$85.00N/AAssumes
6 years ago
Ionis Pharmaceuticals IncIONS
2HoldN/AN/ADowngrades
6 years ago
Voyager Therapeutics IncVYGR
2HoldN/AN/ADowngrades
6 years ago
Bioverativ IncBIVV
3HoldN/AN/ADowngrades
6 years ago
Uniqure NvQURE
1Buy$22.00N/AInitiates Coverage On
6 years ago
Adamas Pharmaceuticals IncADMS
1Buy$85.00N/AInitiates Coverage On
6 years ago
Audentes Therapeutics IncBOLD
2HoldN/AN/ADowngrades
6 years ago
Theravance Biopharma IncTBPH
1BuyN/AN/AInitiates Coverage On
7 years ago
Spark Therapeutics IncONCE
1Hold$83.00N/AInitiates Coverage On
7 years ago
Avexis IncAVXS
1Buy$120.00N/AInitiates Coverage On
7 years ago
Abbvie IncABBV
1Buy$95.00N/AInitiates Coverage On
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.